Search by Drug Name or NDC

NDC 00008-1030-06 Rapamune 1 mg/mL Details

Rapamune 1 mg/mL

Rapamune is a ORAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.. The primary component is SIROLIMUS.

MedlinePlus Drug Summary

Sirolimus is used in combination with other medications to prevent rejection of kidney transplants. Sirolimus is in a class of medications called immunosuppressants. It works by suppressing the body's immune system.

Related Packages: 00008-1030-06
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Sirolimus

Product Information

NDC	00008-1030
Product ID	0008-1030_59172404-9534-45d4-90a6-1aa6c42f7898
Associated GPIs	99404070002020
GCN Sequence Number	043458
GCN Sequence Number Description	sirolimus SOLUTION 1 MG/ML ORAL
HIC3	Z2E
HIC3 Description	IMMUNOSUPPRESSIVES
GCN	50356
HICL Sequence Number	020519
HICL Sequence Number Description	SIROLIMUS
Brand/Generic	Brand
Proprietary Name	Rapamune
Proprietary Name Suffix	n/a
Non-Proprietary Name	SIROLIMUS
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	SOLUTION
Route	ORAL
Active Ingredient Strength	1
Active Ingredient Units	mg/mL
Substance Name	SIROLIMUS
Labeler Name	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Pharmaceutical Class	Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA021083
Listing Certified Through	2024-12-31

Package

NDC 00008-1030-06 (00008103006)

Pricing Information	N/A
NDC Package Code	0008-1030-06
Billing NDC	00008103006
Package	1 CARTON in 1 KIT (0008-1030-06) / 1 BOTTLE, GLASS in 1 CARTON (0008-1030-04) / 60 mL in 1 BOTTLE, GLASS
Marketing Start Date	1999-09-01
NDC Exclude Flag	N